Differential efficacy of gonadotropin-releasing hormone (GnRH) agonist treatment on pedunculated and degenerated myomas: A retrospective study of 630 women

Journal of Obstetrics and Gynaecology

Volumn 20, Issue 5, 2000, Pages 504-506

  Furui, T ^a   Imai, A ^a   Takagi, A ^a   Tamaya, T ^a   Takagi, H ^b   Matsunami, K ^b   Shiraki, S ^c  

^a GIFU UNIVERSITY   (Japan)

^b Matsunami General Hospital   (Japan)

^c Hirano General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN ACETATE; GONADORELIN AGONIST; LEUPRORELIN; NAFARELIN ACETATE; NASANYL;

ADULT; ARTICLE; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBMUCOSA; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME; UTERINE CERVIX; UTERUS MYOMA;

EID: 0033753946     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/014436100434703     Document Type: Article

References (10)

1. Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: Standard-dose therapy followed by reduced-dose therapy
2. Uterine leiomyomata: Etiology, symptomatology, and management
3. Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind, placebo-controlled, multicenter study
4. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist
5. Correlation between shrinkage of uterine leiomyoma treated with buserelin acetate and histopathologic findings of biopsy specimen before treatment
6. The study of the effect of presurgical GnRH agonist treatment for women with uterine leiomyoma; effect on the myoma volume and the operation
7. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: Correlation between T2-weighted images and effect of GnRH analogue
8. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata
9. Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage
10. Clinical predictors for buserelin acetate treatment of uterine fibroids: A prospective study of 40 women